Join the 'Opdivo' group to help and get support from people like you.
Opdivo Support Group
Our support group for Opdivo has 16 questions and 19 members. Updated 17 Jan 2017.
Bristol-Myers Squibb’s Opdivo (nivolumab) is the First Immuno-Oncology Treatment to Receive FDA Approval Based on Overall Survival in Head and Neck Cancer
PRINCETON, N.J.--(BUSINESS WIRE) November 10, 2016 --Bristol-Myers Squibb Company (NYSE:BMY) announced today that the U.S. Food and Drug Administration (FDA) has approved Opdivo (nivolumab) ...
Posted 1 day 3 hours ago • 0 answers
Posted 28 Dec 2016 • 1 answer
Posted 30 Sep 2016 • 0 answers